Patents by Inventor Sethu Sankaranarayanan

Sethu Sankaranarayanan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240109957
    Abstract: The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating a blood disorder (e.g.
    Type: Application
    Filed: October 16, 2020
    Publication date: April 4, 2024
    Inventors: Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20240083989
    Abstract: The present disclosure relates generally to methods of treating a brain injury, preferably a traumatic brain injury, hypoxic brain injury, brain infection, or stroke, comprising administering to a subject an inhibitor of the complement pathway.
    Type: Application
    Filed: August 4, 2023
    Publication date: March 14, 2024
    Inventors: Susanna Rosi, Karen Krukowski, Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20240034775
    Abstract: The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating epilepsy, comprising administering to a subject an inhibitor of the classical complement pathway.
    Type: Application
    Filed: May 5, 2021
    Publication date: February 1, 2024
    Inventors: Jeanne T. Paz, Sethu Sankaranarayanan, Ted Yednock
  • Publication number: 20230391858
    Abstract: The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating a blood disorder (e.g.
    Type: Application
    Filed: October 15, 2021
    Publication date: December 7, 2023
    Inventors: Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20230279103
    Abstract: The present disclosure relates generally to antibodies with a single antigen-binding arm comprising a single antigen-binding arm and an Fc region such as a single-arm antibodies. The present disclosure also relates generally to the use of such antibodies such as treating a disease associated with complement activation.
    Type: Application
    Filed: December 13, 2022
    Publication date: September 7, 2023
    Inventors: Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20200317765
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Application
    Filed: June 25, 2020
    Publication date: October 8, 2020
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • Patent number: 10723788
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: July 28, 2020
    Assignee: Annexon, Inc.
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal
  • Publication number: 20200140533
    Abstract: The present disclosure relates generally to methods of treating a brain injury, preferably a traumatic brain injury, hypoxic brain injury, brain infection, or stroke, comprising administering to a subject an inhibitor of the complement pathway.
    Type: Application
    Filed: November 1, 2019
    Publication date: May 7, 2020
    Inventors: Susanna Rosi, Karen Krukowski, Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20190161535
    Abstract: The present disclosure relates generally to methods of preventing, reducing risk of developing, or treating spinal muscular atrophy, comprising administering to a subject an inhibitor of the complement pathway.
    Type: Application
    Filed: May 9, 2017
    Publication date: May 30, 2019
    Inventors: Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20190151414
    Abstract: The present disclosure relates generally to anti-C4 antibodies and anti-C4b antibodies and methods of using them in the treatment of neurodegenerative disease.
    Type: Application
    Filed: May 10, 2017
    Publication date: May 23, 2019
    Inventors: Ted Yednock, Sethu Sankaranarayanan
  • Publication number: 20170152309
    Abstract: The present disclosure relates generally to anti-C1q antibody Fab fragments and methods of using the same.
    Type: Application
    Filed: November 23, 2016
    Publication date: June 1, 2017
    Applicant: Annexon, Inc.
    Inventors: Ted Yednock, Sethu Sankaranarayanan, Michael Leviten, Arnon Rosenthal